OR Yat Sun,MA Jun,WANG Guoqiang,LONG Jiang,WANG Bin
申请号：
SI201130775
公开号：
SI2618831T1
申请日:
2011.09.20
申请国别(地区):
SI
年份:
2016
代理人:
摘要：
The present invention discloses compounds of Formula I or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit serine protease activity, particularly the activity of hepatitis C virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
